Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KAI-9803 for infarct size reduction in STEMI
NCT00785954Phase 2Completed
- Sponsor
- KAI Pharmaceuticals
- Start
- Nov 2008
- Primary completion
- Jul 2010
- Countries
- 18
01
Overview
Phase 2, randomised, double-blind trial of delcasertib in myocardial infarction (MI), sponsored by KAI Pharmaceuticals. Started Nov 2008; status: completed.
02
Drugs
delcasertib
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00785954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00785954.